HCID 21942621, compound → HCID 21942475, compound

HRID 431914Notes

Reaction equation

HRID 431914 reaction equation
F[C:2]1[C:3]([C:8]2[N:12]=[C:11]([C:13]3[CH:18]=[C:17]([C:19]#[N:20])[CH:16]=[C:15]([F:21])[CH:14]=3)[O:10][N:9]=2)=[N:4][CH:5]=[CH:6][CH:7]=1.[CH3:22][N:23]([CH3:38])[CH2:24][CH2:25][CH2:26][CH2:27][CH2:28][O:29]CCCCCN(C)C.[K]>CN(C)C=O>[CH3:22][N:23]([CH3:38])[CH2:24][CH2:25][CH2:26][CH2:27][CH2:28][O:29][C:2]1[C:3]([C:8]2[N:12]=[C:11]([C:13]3[CH:14]=[C:15]([F:21])[CH:16]=[C:17]([C:19]#[N:20])[CH:18]=3)[O:10][N:9]=2)=[N:4][CH:5]=[CH:6][CH:7]=1

Participants

4

Reactant 2

HCID 21942621HCID 21942621, compoundHCID 86587474HCID 86587474, compound

Product 1

HCID 21942475HCID 21942475, compound

Reagents, catalysts & solvents 1

HCID 6228DimethylformamideSolvent

Procedure

Alternatively, treatment of 3-(3-fluoropyrid-2-yl)-5-(3-fluoro-5-cyanophenyl)-1,2,4-oxadiazole with potassium 5-dimethylaminopentyloxide in N.N-dimethylformamide with a catalytic amount of 1, 4, 7, 10, 13, 16-hexaoxacyclooctadecane (18-crown-6) and heating at 110° C. affords crude product. Standard work up and purification by one or more methods, including silica gel chromatography, recystallization, trituration, and reversed-phase high-performance liquid chromatography (RP-HPLC) affords purified 3-(3-(5-dimethylaminopentyloxy)-pyrid-2-yl)-5-(3-cyano-5-fluorophenyl)-1,2,4-oxadiazole.

Workup

  1. customaffords crude product
  2. customStandard work up and purification by one or more methods
  3. customaffords
  4. custompurified 3-(3-(5-dimethylaminopentyloxy)-pyrid-2-yl)-5-(3-cyano-5-fluorophenyl)-1,2,4-oxadiazole

Sources & evidence

ORD record
ord-d4c74f52c6eb474c950312aec9fba920
Source dataset
uspto-grants-2003_12
Patent number
US06660753B2

Reaction notes

Loading…